GNQ-209P Mutation in Metastatic Uveal Melanoma and Treatment Outcome
Metastatic prognosis in uveal melanoma is assessed by gene expression profiling (GEP) testing of the tumor cells, usually obtained by fine needle aspiration (FNA). GEP has demonstrated high accuracy in distinguishing class I and II tumors, both having different metastatic potential. Transcriptomic s...
Saved in:
Main Authors: | Nagla Abdel Karim, Ihab Eldessouki, Ahmad Taftaf, Deeb Ayham, Ola Gaber, Abouelmagd Makramalla, Zelia M. Correa |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Case Reports in Oncological Medicine |
Online Access: | http://dx.doi.org/10.1155/2018/4256365 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Uveal Melanoma
by: Vasilios P. Papastefanou, et al.
Published: (2011-01-01) -
Genetics of Uveal Melanoma and Cutaneous Melanoma: Two of a Kind?
by: Thomas van den Bosch, et al.
Published: (2010-01-01) -
18F-FDG PET/CT assessment of metabolic tumor burden predicts survival in patients with metastatic posterior uveal melanoma
by: Tine Gadegaard Hindso, et al.
Published: (2025-02-01) -
Spatially resolved transcriptomics reveals gene expression characteristics in uveal melanoma
by: Jing-Ying Xiu, et al.
Published: (2025-01-01) -
Metastasis of Ciliary Body Melanoma to the Contralateral Eye: A Case Report and Review of Uveal Melanoma Literature
by: Nouritza M. Torossian, et al.
Published: (2015-01-01)